Results 111 to 120 of about 5,266 (185)

Bis-Oxadiazole Assemblies as NO-Releasing Anticancer Agents. [PDF]

Pharmaceutics
Matnurov EM, Stebletsova IA, Larin AA, Arakelyan J, Ananyev IV, Gushchin AL, Fershtat LL, Babak MV.   +7 more
europepmc   +1 more source

Novel Isoxazoline-1, 2, 4-oxadiazoles: Synthesis, Characterization and Antimicrobial screening

Journal of Chemical and Pharmaceutical Sciences, 2018
K.B. Umesha, D. Shridevi Doddamani, N. Srikantamurthy   +2 more
openaire   +1 more source

A novel and sustainable synthesis-functionalization strategy for the oxidative cyclization towards 2,5-disubstituted-1,3,4-oxadiazoles using bentonite-supported copper(i) iodide as a green catalyst. [PDF]

RSC Adv
Tran VQ, Tran DM, Tran MH, Tran PH, Nguyen HT.   +4 more
europepmc   +1 more source

Synthesis, Characterization and Antimicrobial Screening of Sulphonamide Based 1, 3, 4-Oxadiazoles

International Journal of Chemical and Physical Sciences, 2018
Abhishek Joshi, Deepkumar Joshi, Kalpesh Parikh, Piyush Dholaria   +3 more
openaire   +1 more source

Tri-1,3,4-Oxadiazoles Modified with Nitroimine: Balancing Energy, Sensitivity, and Thermal Stability. [PDF]

Molecules
Chen F, Yu Q, Li L, Peng K, Zhu C, Yi W.
europepmc   +1 more source

Activity Profiling of Nitro-Substituted Di(Hetero)Aryl 1,3,4- and 1,2,4-Oxadiazoles: Antimicrobial, Cholinesterase Inhibition and Antioxidant Potential. [PDF]

Arch Pharm (Weinheim)
Šikorová E, Štěpánková Š, Frýbová E, Konečná K, Korbielová J, Švarcová M, Janďourek O, Pflégr V, Bősze S, Krátký M.   +9 more
europepmc   +1 more source

A two-decade overview of oxadiazole derivatives as promising anticancer agents. [PDF]

RSC Adv
Salem M, El-Adl K, El-Morsy A, Abulkhair HS.   +3 more
europepmc   +1 more source

Structural and computational supported development of 2,5-disubstituted-1,3,4-oxadiazole analogues as active LOX, urease, and α-glucosidase inhibitors. [PDF]

Sci Rep
Javid J, Aziz-Ur-Rehman, Iqbal J, Ahmed I, Bhatti N, Kuznetsov A, Zafar F, Ayub MA, Mohammed OA, Al-Mijalli SH, Iqbal M, Shah SAA.   +11 more
europepmc   +1 more source

Radiolabeling and evaluation of ⁶⁴⁺⁶⁷Cu-2,2'-(1,2,4-Oxadiazole-3,5-diyl)di aniline as a theranostic agent for solid tumors. [PDF]

Sci Rep
Gizawy MA, Ayoup MS, Kodous AS, Abdelrahman MT, Motaleb MA.   +4 more
europepmc   +1 more source